Antimicrobials: Drug Resistance

(asked on 20th July 2023) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the funding for antimicrobial resistance research through the Global AMR Innovation Fund, whether his Department has a long-term investment strategy for stimulating non-profit innovation to help tackle antimicrobial resistance.


Answered by
Maria Caulfield Portrait
Maria Caulfield
Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
This question was answered on 4th September 2023

Research and innovation are crucial pillars of activity under the Government’s five-year National Action Plan (NAP), covering the period 2019 to 2024, for tackling antimicrobial resistance (AMR) and will continue to be a priority under the next NAP. The Government is currently developing this second five-year NAP, which will run from 2024 to 2029. This includes development of a series research priorities, commitments, and deliverables.

As part of this approach, the Global AMR Innovation Fund (GAMRIF) is a One Health UK aid fund that supports research and development around the world to reduce the threat of AMR in humans, animals, and the environment for the benefit of people in low- and middle-income countries. GAMRIF collaborates with academia, non-profit global initiatives, industry, and governments to support innovation and product development, while also ensuring sustained investment from other global donors to tackle AMR.

Reticulating Splines